DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Lifevantage Corporation (LXRX)
« Back to company indexLXRX Chatter Timeline
Stock Ticker for LXRX
Most Active Tweeters for LXRX
| User | Tweets |
|---|---|
| @Tickeron | 11 |
| @dispatchtribune | 5 |
| @ConsumerFeed | 4 |
| @WatchlistN | 4 |
| @AmericanBanking | 3 |
Recent Tweets for LXRX
 |
@otcdynamics $LXRX Lexicon Pharmaceuticals Announces Poster Presentation at the ASCO 2020 Gastrointestinal Cancers Symposium https://t.co/apewDPSZ73 4:01pm |
 |
@newsfilterio Lexicon Pharmaceuticals Announces Poster Presentation at the ASCO 2020 Gastrointestinal Cancers Symposium $LXRX https://t.co/TZEJSoCEKa 4:01pm |
 |
@Tickeron $LXRX's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/34RCIpYTRL January 19th 2020, 10:01pm |
 |
@gcassidy718 $LXRX Hoping to exit this position at some point . . . -4.72 % change recently https://t.co/GvztssB0iO January 19th 2020, 8:01pm |
|
@gcassidy718 $LXRX significant stock price movement -4.72 % change recently https://t.co/GvztssB0iO January 18th 2020, 10:01pm |
 |
@TranscriptDaily -$0.76 EPS Expected for Lexicon Pharmaceuticals, Inc. $LXRX This Quarter https://t.co/ckPnAuaqbt January 18th 2020, 8:01pm |
|
@newsfilterio Lexicon Pharmaceuticals Expected to Announce Earnings of -$0.76 Per Share $LXRX https://t.co/fGwlj0DOu3 January 18th 2020, 8:01pm |
 |
@stocknewstimes Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Earnings of -$0.76 Per Share https://t.co/FZcuat0HcN January 18th 2020, 8:01pm |
|
@TranscriptDaily Lexicon Pharmaceuticals $LXRX Downgraded by Zacks Investment Research https://t.co/hRXIE6K3hi January 18th 2020, 10:01am |
|
@Tickeron $LXRX's price moved above its 50-day Moving Average on January 13, 2020. View odds for this and other indicators:… https://t.co/xiYJ8nWDvP January 17th 2020, 11:01pm |
 |
@BlueBioNow $LXRX What happened??? why the bounce?? -4.60 % change recently https://t.co/e90khvbZCK January 17th 2020, 6:01pm |
|
@Tickeron $LXRX's price moved above its 50-day Moving Average on January 13, 2020. View odds for this and other indicators:… https://t.co/OQ7SqjL8wt January 16th 2020, 11:01pm |
 |
@fintel_io $LXRX / Lexicon Pharmaceuticals files form 8-K - Entry into a Material Definitive Agreement, Financial Statements a… https://t.co/yjA0GgaGyz January 16th 2020, 4:01pm |
 |
@StockTexts $LXRX Lexicon Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/y5J9l2bIIs January 16th 2020, 4:01pm |
 |
@OlympiaReport Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post Quarterly Sales of $10.59 Million https://t.co/5frfm7GmuB January 16th 2020, 1:01pm |
 |
@WatchlistN -$0.76 EPS Expected for Lexicon Pharmaceuticals, Inc. $LXRX This Quarter https://t.co/Q8bCATPhpx January 16th 2020, 1:01pm |
 |
@dispatchtribune Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post Earnings of -$0.76 Per Share https://t.co/ec0aNjN2Mv January 16th 2020, 1:01pm |
 |
@WeekHerald Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post Quarterly Sales of $10.59 Million https://t.co/rf7BDaEtiG January 16th 2020, 12:01pm |
 |
@dailypoliticaln Lexicon Pharmaceuticals $LXRX Rating Lowered to Hold at Zacks Investment Research https://t.co/G7nOU4dM4X January 16th 2020, 12:01pm |
 |
@ConsumerFeed Lexicon Pharmaceuticals $LXRX Stock Rating Lowered by Zacks Investment Research https://t.co/Rcbks3c7iT January 16th 2020, 12:01pm |
 |
@Easy_Money_weee $LXRX and $FCEL nice day so far. January 16th 2020, 9:01am |
 |
@TheMarketsDaily Lexicon Pharmaceuticals, Inc. $LXRX Short Interest Update https://t.co/mlQCFcttHE January 15th 2020, 7:01pm |
|
@stocknewstimes Lexicon Pharmaceuticals, Inc. $LXRX Short Interest Update https://t.co/UONX7Hwxdk January 15th 2020, 7:01pm |
|
@gcassidy718 $LXRX "Everything is impossible until someone does it" 2.76 % change recently https://t.co/GvztssB0iO January 15th 2020, 7:01pm |
|
@dispatchtribune Lexicon Pharmaceuticals $LXRX Downgraded to “Hold” at Zacks Investment Research https://t.co/PYhpg8hRZT January 15th 2020, 5:01pm |
|
@WatchlistN Lexicon Pharmaceuticals $LXRX Downgraded to “Hold” at Zacks Investment Research https://t.co/D0zYZS7MKh January 15th 2020, 5:01pm |
|
@WatchlistN Short Interest in Lexicon Pharmaceuticals, Inc. $LXRX Grows By 17.8% https://t.co/L0t1vIPaHT January 15th 2020, 3:01pm |
|
@OlympiaReport Short Interest in Lexicon Pharmaceuticals, Inc. $LXRX Grows By 17.8% https://t.co/6SPBx23nLQ January 15th 2020, 3:01pm |
 |
@SerialTrader72 $LXRX could fly very soon ??? January 15th 2020, 11:01am |
|
@BlueBioNow $LXRX was oversold imo -4.79 % https://t.co/e90khvbZCK January 15th 2020, 7:01am |
|
@WatchlistN Lexicon Pharmaceuticals $LXRX Stock Rating Upgraded by Zacks Investment Research https://t.co/HYgKYrhhrq January 15th 2020, 4:01am |
|
@ConsumerFeed Lexicon Pharmaceuticals $LXRX Stock Rating Upgraded by Zacks Investment Research https://t.co/ctpALUzuwP January 15th 2020, 4:01am |
 |
@StockConsultant $LXRX Lexicon Pharmaceuticals stock watch, attempting to move higher off 4.18 support area #investing101 #stockpicks https://t.co/dWpvkEsVz1 January 14th 2020, 8:01am |
 |
@TickerReport Brokerages Expect Lexicon Pharmaceuticals, Inc. $LXRX Will Announce Earnings of -$0.76 Per Share https://t.co/wCDjcMHHvp January 14th 2020, 6:01am |
 |
@ThisLincolnian Zacks: Brokerages Expect Lexicon Pharmaceuticals, Inc. $LXRX Will Post Earnings of -$0.76 Per Share https://t.co/nUzCR8XY3V January 14th 2020, 6:01am |
 |
@EnterpriseLeade Lexicon Pharmaceuticals $LXRX Rating Increased to Buy at Zacks Investment Research https://t.co/h5l2ZHPABi January 14th 2020, 3:01am |
|
@EnterpriseLeade Lexicon Pharmaceuticals $LXRX Lowered to “Hold” at Zacks Investment Research https://t.co/mRU0b3HlMH January 14th 2020, 3:01am |
|
@Tickeron $LXRX in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators:… https://t.co/op2UvFKILm January 13th 2020, 11:01pm |
|
@dailypoliticaln Lexicon Pharmaceuticals $LXRX Trading 6.2% Higher https://t.co/rhcB3oqamT January 13th 2020, 11:01pm |
 |
@AmericanBanking Short Interest in Lexicon Pharmaceuticals, Inc. $LXRX Rises By 17.8% https://t.co/SkAnX3vbfp #stocks January 13th 2020, 9:01am |
 |
@bbnsnews Short Interest in Lexicon Pharmaceuticals, Inc. $LXRX Rises By 17.8% https://t.co/SlrIoyK0Eh January 13th 2020, 9:01am |
|
@dispatchtribune Short Interest in Lexicon Pharmaceuticals, Inc. $LXRX Rises By 17.8% https://t.co/ph2YKZpwrG January 13th 2020, 9:01am |
|
@bbnsnews Lexicon Pharmaceuticals, Inc. $LXRX Expected to Announce Quarterly Sales of $10.59 Million https://t.co/k9JyVGIAhG January 13th 2020, 3:01am |
 |
@ZolmaxNews Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post Quarterly Sales of $10.59 Million https://t.co/5I7DhJ2iMe January 13th 2020, 3:01am |
|
@AmericanBanking Lexicon Pharmaceuticals, Inc. $LXRX Expected to Post Quarterly Sales of $10.59 Million https://t.co/9U8clIoCHR #stocks January 13th 2020, 3:01am |
|
@TickerReport Lexicon Pharmaceuticals $LXRX Rating Increased to Buy at Zacks Investment Research https://t.co/Z1Yujo9UuC January 13th 2020, 2:01am |
|
@ZolmaxNews Lexicon Pharmaceuticals $LXRX Upgraded to Buy at Zacks Investment Research https://t.co/AdIhMFrZ5p January 13th 2020, 2:01am |
|
@Tickeron $LXRX in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators:… https://t.co/bnfzOZsyYY January 13th 2020, 12:01am |
|
@newsfilterio Lexicon Pharmaceuticals Upgraded to Buy by Zacks Investment Research $LXRX https://t.co/vy0FhGaR5S January 12th 2020, 1:01pm |
|
@TheMarketsDaily Lexicon Pharmaceuticals $LXRX Upgraded to Buy by Zacks Investment Research https://t.co/ShW7N3SWw8 January 12th 2020, 1:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.